Article Sidebar

Submitted
Oct 21, 2024
Accepted
Dec 28, 2024
Published
Dec 30, 2024
Download
pdf
Statistic
Read Counter : 20 Download : 12

Downloads

Download data is not yet available.

Main Article Content

Abstract

Hypertensive nephropathy (HN) is a common complication of chronic hypertension that leads to kidney damage. This study aimed to identify potential biomarkers and key pathways associated with HN using bioinformatics tools. Gene data related to HN were retrieved from GeneCards and the Comparative Toxicogenomics Database (CTD), resulting in 89 genes from GeneCards and 10,898 genes from CTD. A Venn diagram revealed 58 overlapping genes, which were then analyzed using Protein-Protein Interaction (PPI) networks and the CytoHubba plugin in Cytoscape. The Maximal Clique Centrality (MCC) algorithm identified 10 hub genes, including ACE, AGT, ACE2, AGTR1, and AGTR2, integral to the renin- angiotensin-aldosterone system (RAAS). Functional enrichment analysis using Gene Ontology (GO) and KEGG pathways revealed that the most significant biological process was regulating systemic arterial blood pressure by the Renin-Angiotensin system, with the renin-angiotensin system pathway being the most highly enriched. Further visualization using ShinyGo highlighted the involvement of key genes in the RAAS pathway. These findings provide valuable insights into the molecular mechanisms underlying HN and suggest that bioinformatics approaches can aid in the identification of specific biomarkers for early diagnosis, non-invasive monitoring, and targeted treatments for HN in the future.

Keywords

hypertensive nephropathy biomarkers bioinformatics genes

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
1.
Fajarido A, Fadilah F, Wawaimuli Arozal. Identification of Potential Biomarkers for Hypertensive Nephropathy by Bioinformatics Analysis. EKSAKTA [Internet]. 2024Dec.30 [cited 2025Jan.15];25(04):484-97. Available from: https://eksakta.ppj.unp.ac.id/index.php/eksakta/article/view/537

References

  1. Wang, Z., Liu, Z., Yang, Y., & Kang, L. (2020). Identification of biomarkers and pathways in hypertensive nephropathy based on the ceRNA regulatory network. BMC nephrology, 21, 1-10.
  2. Lucero, C. M., Prieto-Villalobos, J., Marambio-Ruiz, L., Balmazabal, J., Alvear, T. F., Vega, M., ... & Gómez, G. I. (2022). Hypertensive nephropathy: unveiling the possible involvement of hemichannels and pannexons. International Journal of Molecular Sciences, 23(24), 15936.
  3. Ameer, O. Z. (2022). Hypertension in chronic kidney disease: What lies behind the scene. Frontiers in pharmacology, 13, 949260.
  4. Kostovska, I., Tosheska Trajkovska, K., Labudović, D., Kostovski, O., & Spasovski, G. (2023). Urinary Nephrin as an Early Biomarker of Hypertensive Nephropathy. Acta clinica Croatica, 62(4), 635-643.
  5. Kostovska, I., Tosheska Trajkovska, K., Labudovikj, D., Cekovska, S., Kostovski, O., & Spasovski, G. (2023). Assessment of urinary podocalyxin as a biomarker of early diagnosis of hypertensive nephropathy. The Ukrainian Biochemical Journal.
  6. Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., ... & Von Mering, C. (2023). The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic acids research, 51(D1), D638-D646.
  7. Ali, A., & Sheng-Chang, C. (2020). Characterization of well logs using K-mean cluster analysis. Journal of Petroleum Exploration and Production Technology, 10, 2245-2256.
  8. Doncheva, N. T., Morris, J. H., Gorodkin, J., & Jensen, L. J. (2018). Cytoscape StringApp: network analysis and visualization of proteomics data. Journal of proteome research, 18(2), 623-632.
  9. Oti, E. U., Olusola, M. O., Eze, F. C., & Enogwe, S. U. (2021). Comprehensive review of K-Means clustering algorithms. criterion, 12, 22-23.
  10. Rauf, S., Ullah, S., Abid, M. A., Ullah, A., Khan, G., Khan, A. U., ... & Faisal, S. (2024). A computational study of gene expression patterns in head and neck squamous cell carcinoma using TCGA data. Future Science OA, 10(1), 2380590.
  11. Ge, S. X., Jung, D., & Yao, R. (2020). ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics, 36(8), 2628-2629.
  12. Barshir, R., Fishilevich, S., Iny-Stein, T., Zelig, O., Mazor, Y., Guan-Golan, Y., ... & Lancet, D. (2021). GeneCaRNA: a comprehensive gene-centric database of human non-coding RNAs in the GeneCards suite. Journal of molecular biology, 433(11), 166913.
  13. Davis, A. P., Wiegers, T. C., Johnson, R. J., Sciaky, D., Wiegers, J., & Mattingly, C. J. (2023). Comparative toxicogenomics database (CTD): update 2023. Nucleic acids research, 51(D1), D1257-D1262.
  14. Hallee, L., & Gleghorn, J. P. (2023). Protein-Protein Interaction Prediction is Achievable with Large Language Models. bioRxiv, 2023-06.
  15. Ramos, R. H., Ferreira, C. D. O. L., & Simao, A. (2024). Human protein–protein interaction networks: A topological comparison review. Heliyon.
  16. Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019). Obesity, kidney dysfunction and hypertension: mechanistic links. Nature reviews nephrology, 15(6), 367-385.
  17. De Bhailis, Á. M., & Kalra, P. A. (2022). Hypertension and the kidneys. British journal of hospital medicine, 83(5), 1-11.
  18. Ames, M. K., Atkins, C. E., & Pitt, B. (2019). The renin‐angiotensin‐aldosterone system and its suppression. Journal of veterinary internal medicine, 33(2), 363-382.
  19. Guo, L., Lin, M., Cheng, Z., Chen, Y., Huang, Y., & Xu, K. (2019). Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer. PeerJ, 7, e7899.
  20. A. Asadzadeh, N. Ghorbani, and K. Dastan (2023). Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study, Int J Reprod Biomed, vol. 21, no. 10, pp. 809–818.
  21. Kunvariya, A. D., Dave, S. A., Modi, Z. J., Patel, P. K., & Sagar, S. R. (2023). Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases. Heliyon, 9(5).
  22. Costa, L. B., Perez, L. G., Palmeira, V. A., Macedo e Cordeiro, T., Ribeiro, V. T., Lanza, K., & Simoes e Silva, A. C. (2020). Insights on SARS-CoV-2 molecular interactions with the renin-angiotensin system. Frontiers in Cell and Developmental Biology, 8, 559841.
  23. Bhushan, S., Xiao, Z., Gao, K., Mao, L., Chen, J., Ping, W., ... & Zhang, Z. (2023). Role and interaction between ACE1, ACE2 and their related genes in cardiovascular disorders. Current Problems in Cardiology, 48(8), 101162.
  24. Bode, M., Herrnstadt, G. R., Dreher, L., Ehnert, N., Kirkerup, P., Lindenmeyer, M. T., ... & Wenzel, U. O. (2024). Deficiency of complement C3a and C5a receptors does not prevent angiotensin II–induced hypertension and hypertensive end-organ damage. Hypertension, 81(1), 138-150.
  25. Peng, Z., Xu, Q., Hu, W., & Cheng, Y. (2023). Review on Molecular Mechanism of Hypertensive Nephropathy. Current Pharmaceutical Design, 29(32), 2568-2578.
  26. Costantino, V. V., Gil Lorenzo, A. F., Bocanegra, V., & Vallés, P. G. (2021). Molecular mechanisms of hypertensive nephropathy: renoprotective effect of losartan through Hsp70. Cells, 10(11), 3146.
  27. Evangelista, J. E., Xie, Z., Marino, G. B., Nguyen, N., Clarke, D. J., & Ma’ayan, A. (2023). Enrichr-KG: bridging enrichment analysis across multiple libraries. Nucleic acids research, 51(W1), W168-W179.
  28. Zeng, Y., Jiang, Y., Huang, Z., Li, K., & Zhou, Y. (2023). Association between AGTR1 (c. 1166 A> C) Polymorphisms and Kidney Injury in Hypertension. Frontiers in Bioscience-Landmark, 28(7), 146.
  29. Han, W., Wang, M., Zhai, X., Gan, Q., Guan, S., & Qu, X. (2020). Chemical renal denervation-induced upregulation of the ACE2/Ang (1-7)/Mas axis attenuates blood pressure elevation in spontaneously hypertensive rats. Clinical and Experimental Hypertension, 42(7), 661-668.
  30. Wu, C., Ye, D., Mullick, A. E., Li, Z., Danser, A. J., Daugherty, A., & Lu, H. S. (2020). Effects of renin-angiotensin inhibition on ACE2 and TMPRSS2 expression: insights into COVID-19. bioRxiv, 2020-06.